|Last Price$6.55||Day Change (%)0.46%|
|Open Price$6.54||Day Change ($)0.03|
|Day Range6.41–6.72||52-Week Range3.61–8.37|
As of Fri 8/26/2016 5:00:00 PM | USD
Global Prostate Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Camurus, MediaPharma, Targovax - Research and Markets
Progenics Pharmaceuticals PGNX and partner Wyeth WYE announced Thursday that both the Food and Drug Administration and the European Medicines Agency have accepted new drug applications for subcutaneous MNTX, which aims to treat postoperative ileus and opioid bowel dysfunction. We are leaving our ...